Related references
Note: Only part of the references are listed.The FoxO-BNIP3 axis exerts a unique regulation of mTORC1 and cell survival under energy stress
A. Lin et al.
ONCOGENE (2014)
Current Perspective on the Global and United States Cancer Burden Attributable to Lifestyle and Environmental Risk Factors
David Schottenfeld et al.
ANNUAL REVIEW OF PUBLIC HEALTH, VOL 34 (2013)
Signalling pathways regulating muscle mass in ageing skeletal muscle. The role of the IGF1-Akt-mTOR-FoxO pathway
M. Sandri et al.
BIOGERONTOLOGY (2013)
FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell survival
Prasanth Puthanveetil et al.
CARDIOVASCULAR RESEARCH (2013)
The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle
Laura A. A. Gilliam et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Protein breakdown in muscle wasting: Role of autophagy-lysosome and ubiquitin-proteasome
Marco Sandri
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Doxorubicin-induced markers of myocardial autophagic signaling in sedentary and exercise trained animals
Ashley J. Smuder et al.
JOURNAL OF APPLIED PHYSIOLOGY (2013)
Mechanical Unloading Activates FoxO3 to Trigger Bnip3-Dependent Cardiomyocyte Atrophy
Dian J. Cao et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
The central role of myostatin in skeletal muscle and whole body homeostasis
B. Elliott et al.
ACTA PHYSIOLOGICA (2012)
Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes
Laura A. A. Gilliam et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
Mitofusins and the mitochondrial permeability transition: the potential downside of mitochondrial fusion
Kyriakos N. Papanicolaou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Long-term physical exercise induces changes in sirtuin 1 pathway and oxidative parameters in adult rat tissues
S. Bayod et al.
EXPERIMENTAL GERONTOLOGY (2012)
Foxo/Atrogin induction in human and experimental myositis
Han-Kyu Lee et al.
NEUROBIOLOGY OF DISEASE (2012)
TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness
Laura A. A. Gilliam et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
Exercise protects against doxorubicin-induced oxidative stress and proteolysis in skeletal muscle
Ashley J. Smuder et al.
JOURNAL OF APPLIED PHYSIOLOGY (2011)
Exercise protects against doxorubicin-induced markers of autophagy signaling in skeletal muscle
Ashley J. Smuder et al.
JOURNAL OF APPLIED PHYSIOLOGY (2011)
DOXORUBICIN CAUSES DIAPHRAGM WEAKNESS IN MURINE MODELS OF CANCER CHEMOTHERAPY
Laura A. A. Gilliam et al.
MUSCLE & NERVE (2011)
Bnip3 as a Dual Regulator of Mitochondrial Turnover and Cell Death in the Myocardium
Asa B. Gustafsson
PEDIATRIC CARDIOLOGY (2011)
FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70
Sarah M. Senf et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72
Andreas N. Kavazis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Reactive oxygen species are signalling molecules for skeletal muscle adaptation
Scott K. Powers et al.
EXPERIMENTAL PHYSIOLOGY (2010)
ROS-MEDIATED ACTIVATION OF NF-kappa B AND FOXO DURING MUSCLE DISUSE
Stephen L. Dodd et al.
MUSCLE & NERVE (2010)
Smad2 and 3 transcription factors control muscle mass in adulthood
Roberta Sartori et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Regulation of mitofusin-2 expression in skeletal muscle
Antonio Zorzano
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2009)
Activation of the ubiquitin-proteasome system in doxorubicin cardiomyopathy
Mark J. Ranek et al.
CURRENT HYPERTENSION REPORTS (2009)
Doxorubicin acts through tumor necrosis factor receptor subtype 1 to cause dysfunction of murine skeletal muscle
Laura A. A. Gilliam et al.
JOURNAL OF APPLIED PHYSIOLOGY (2009)
Differential Contractile Impairment of Fast- and Slow-Twitch Skeletal Muscles in a Rat Model of Doxorubicin-Induced Congestive Heart Failure
Mert Ertunc et al.
PHARMACOLOGY (2009)
Downstream of Akt: FoxO3 and m TOR in the regulation ofautophagy in skeltal muscle
Cristina Mammucari et al.
AUTOPHAGY (2008)
The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy
A. J. Murton et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Fuel economy in food-deprived skeletal muscle: signaling pathways and regulatory mechanisms
Pieter de Lange et al.
FASEB JOURNAL (2007)
Adriamycin-induced oxidative mitochondrial cardiotoxicity
J. M. Berthiaume et al.
CELL BIOLOGY AND TOXICOLOGY (2007)
Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors
David L. Allen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
PGC-1α a protects skeletal muscle from atrophy by suppressing Fox03 action and atrophy-specific gene transcription
Marco Sandri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Defective one- or two-electron reduction of the anticancer anthracycline epirubicin in human heart -: Relative importance of vesicular sequestration and impaired efficiency of electron addition
E Salvatorelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Exercise training attenuates acute doxorubicin-induced cardiac dysfunction
AJ Chicco et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis
A Ascensao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Monitoring cardiac function in patients receiving doxorubicin
P Lu
SEMINARS IN NUCLEAR MEDICINE (2005)
The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system
S Pich et al.
HUMAN MOLECULAR GENETICS (2005)
Transcriptional coactivator PGC-1α controls the energy state and contractile function of cardiac muscle
Z Arany et al.
CELL METABOLISM (2005)
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
M Sandri et al.
CELL (2004)
The estrogen-related receptor α (ERRα) functions in PPARγ coactivator 1α (PGC-1α)-induced mitochondrial biogenesis
SN Schreiber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Bioenergetic analysis of peroxisome proliferator-activated receptor γ coactivators 1α and 1β (PGC-1α and PGC-1β) in muscle cells
J St-Pierre et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1
K Baar et al.
FASEB JOURNAL (2002)
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
MD Gomes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Identification of ubiquitin ligases required for skeletal muscle atrophy
SC Bodine et al.
SCIENCE (2001)
Peroxisome proliferator-activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
JJ Lehman et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
